Biogen Inc.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spina…
Drug Manufacturers - General
US, Cambridge [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Biogen Inc. (BIIB) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Manufacturers—General Average | - - | - - | - - | 143,536.59 | 38,161.88 | 3,463.18 | 11,756.27 | -4,256.93 | 0.01 | -3.0152 | 67.70 | 0.5862 | 0.0086 | 0.00 | 0.07 | 2.3688 | - - | ||
| Maximum | - - | - - | - - | 854,616.00 | 515,874.00 | 44,471.00 | 133,091.00 | 1,294.00 | 0.04 | 76.3636 | 1,087.57 | 1.0000 | 0.2558 | 0.04 | 0.53 | 21.1421 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 77.00 | -82.00 | -1,283.00 | -63,834.00 | 0.00 | -311.9276 | -0.15 | 0.0683 | -0.9021 | -0.08 | -0.04 | 0.0000 | - - | ||
| AbbVie Inc. ABBV | 176.95 | 5.22 3.04% | 7,841 vs. 5,489 | 312,695.00 | 12,310.00 | 1,369.00 | 3,847.00 | -2,384.00 | 0.7700 | 58.3938 | 0.0087 | 0.6684 | 0.1112 | 0.1710 | 0.0092 | 0.7229 | 1,767.00 | ||
| GSK plc GLAXF | 16.85 | 0.00 0.00% | 0 vs. 4 | 68,730.00 | 7,363.00 | 1,046.00 | 376.00 | 7,935.00 | 0.2600 | 15.5725 | 0.0087 | 0.7369 | 0.1421 | 0.0756 | 0.0179 | 0.5737 | 4,078.00 | ||
| Gilead Sciences, Inc. GILD | 90.19 | 0.43 0.48% | 4,427 vs. 6,704 | 112,401.00 | 6,686.00 | -4,170.00 | 2,114.00 | 10,656.00 | -3.3400 | -5.4485 | 0.0109 | 0.7679 | -0.6237 | -0.2378 | -0.0741 | 0.8243 | 1,246.00 | ||
| Bristol-Myers Squibb Company BMY | 58.87 | 0.64 1.10% | 7,369 vs. 11,013 | 119,398.00 | 11,865.00 | -11,911.00 | 2,550.00 | 15,640.00 | -5.8900 | -2.2500 | 0.0113 | 0.7529 | -1.0039 | -0.7223 | -0.1203 | 0.9190 | 2,028.00 | ||
| Pfizer Inc. PFE | 25.65 | 0.52 2.07% | 41,844 vs. 36,852 | 145,358.00 | 14,879.00 | 3,115.00 | 387.00 | 121,318.00 | 0.5500 | 12.5852 | 0.0151 | 0.7056 | 0.2094 | 0.0338 | 0.0141 | 0.5659 | 5,666.00 | ||
| Amgen Inc. AMGN | 294.53 | 4.63 1.60% | 2,851 vs. 2,190 | 158,319.00 | 7,396.00 | -113.00 | 459.00 | -27,870.00 | -0.2100 | -335.6404 | 0.0080 | 0.5673 | -0.0153 | -0.0225 | -0.0012 | 0.8362 | 537.00 | ||
| Merck & Co., Inc. MRK | 99.18 | -0.68 -0.68% | 14,028 vs. 9,812 | 250,889.00 | 15,809.00 | 4,762.00 | 2,229.00 | 56,697.00 | 1.8800 | 17.4190 | 0.0059 | 0.7511 | 0.3012 | 0.1180 | 0.0450 | 0.7284 | 2,529.00 | ||
| Johnson & Johnson JNJ | 155.17 | -0.33 -0.21% | 5,561 vs. 6,399 | 373,590.00 | 21,382.00 | 3,255.00 | 2,850.00 | 153,378.00 | 1.3500 | 29.1832 | 0.0076 | 0.6878 | 0.1522 | 0.0465 | 0.0189 | 0.8448 | 2,407.00 | ||
| Biogen Inc. BIIB | 157.90 | -0.11 -0.07% | 1,701 vs. 1,313 | 23,009.00 | 2,200.00 | 393.00 | 432.00 | 18,021.00 | 2.7100 | 19.8229 | 0.0000 | 0.6865 | 0.1788 | 0.0259 | 0.0148 | 0.9539 | 145.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.